Abstract:Objective: To study the role of human antigen R (HuR) regulated transforming growth factor β1 (TGF-β1) expression in airway smooth muscle cells under the stimulation of platelet-derived growth factor (PDGF). Methods: Airway smooth muscle (ASM) cells were cultured at 37 ℃ and 5% CO2 in dulbecco's modified eagle medium (DMEM) cell medium. Cells at passages between 4 and 11 were divided into different groups according to the different compounds added. For control group, no compounds were administrated. For PDGF group, cells were stimulated with PDGF (20 μg/L) and cultured for an additional time. Cells were harvested and real-time PCR was used to measure mRNA level and Western blotting to detect protein level of HuR and TGF-β1 in ASM cells for different groups. Cells were divided into HuR siRNA group and control group. RNA-interference was used to determine whether lowering HuR expression could decrease PDGF-induced TGF-β1 expression in HuR siRNA group and control group after the stimulation of PDGF for indicated times. Western blotting analysis was used to test the expression of TGF-β1 after interrupting HuR expression. The concentration of TGF-β1 in the cultured serum of HuR siRNA group and control group for 0, 6, 12 h under the stimulation of PDGF was measured by enzyme-link immunosorbent assay (ELISA). Cells were divided into control group, control+ PDGF 6 h group, HuR siRNA group and HuR siRNA+ PDGF 6 h group, then the half-life of TGF-β1 mRNA in different groups was determined by treating ASM cells with the transcriptional inhibitor actinomycin D (10 mg/L) for 0, 4, 8 and 12 h. Results: PDGF treatment for 0, 6, 12 and 24 h significantly promoted HuR mRNA and protein expression and the relative levels were 1.00±0.00, 1.35±0.14, 1.73±0.17, 2.07±0.10; 0.51±0.10, 0.67±0.05, 0.83±0.07, 0.95±0.02 (all P<0.05). Similar alterations could also be demonstrated at TGF-β1 mRNA and protein. The relative expression was 1.00±0.00, 1.27±0.06, 1.60±0.10, 1.87±0.10; 0.72±0.09, 0.87±0.07, 1.13±0.12, 1.33±0.05 (6 h versus 12 h and 12 h versus 24 h, P<0.05). HuR expression decreased 21.9% in HuR siRNA group compared with control group under the stimulation of PDGF for 12 h. HuR silencing also decreased PDGF-induced TGF-β1 over-expression in ASM cells. In the control group, the relative protein levels of PDGF treatment for 0, 6 and 12 h were 0.70±0.05, 0.89±0.06, 1.06±0.05 and the protein levels in HuR siRNA group were 0.67±0.09, 0.77±0.03, 0.89±0.05 (all P<0.05). The concentration of TGF-β1 in the cultured serum was measured by ELISA and the outcomes were (773.33±16.32, 877.97±16.03, 3 060.34±82.53) ng/L in control group for 0, 6 and 12 h. Under the same condition, the outcomes of HuR siRNA group were (277.33±9.93, 407.77±7.14, 828.05±11.67) ng/L (both P<0.05). Actinomycin D disturbed the process of transcription and the half-life of TGF-β1 mRNA in HuR siRNA group showed no significant change compared with the HuR siRNA+ PDGF 6 h group (P>0.05). However, compared with control group and control + PDGF 6 h group, the half-life of TGF-β1 mRNA in HuR siRNA group showed significant change (P<0.05). Conclusions: PDGF can elevate TGF-β1 expression in ASM cells. HuR regulates TGF-β1 expression by promoting its mRNA stability.

PDGF-induced airway smooth muscle proliferation is associated with Human antigen R activation and could be weakened by AMPK activation

Human Antigen R Regulates TGF-β1 Expression in Airway Smooth Muscle Cells under the Stimulation of Platelet-Derived Growth Factor

Activation of AMPK Α2 Inhibits Airway Smooth Muscle Cells Proliferation

miR-19 targets PTEN and mediates high mobility group protein B1(HMGB1)-induced proliferation and migration of human airway smooth muscle cells

Activation of AMPK Inhibits TGF-β1-induced Airway Smooth Muscle Cells Proliferation and Its Potential Mechanisms

Activation of PPARγ Inhibits HDAC1-mediated Pulmonary Arterial Smooth Muscle Cell Proliferation and Its Potential Mechanisms.

HB-EGF–Promoted Airway Smooth Muscle Cells and Their Progenitor Migration Contribute to Airway Smooth Muscle Remodeling in Asthmatic Mouse

ABCA1 Inhibits PDGF‐induced Proliferation and Migration of Rat Airway Smooth Muscle Cell Through Blocking TLR2/NF‐κB/NFATc1 Signaling

Activation of peroxisome proliferation–activated receptor‐γ inhibits transforming growth factor‐β1‐induced airway smooth muscle cell proliferation by suppressing Smad–miR‐21 signaling

Activation of AMPK Inhibits PDGF-induced Pulmonary Arterial Smooth Muscle Cells Proliferation and Its Potential Mechanisms.

Up-regulation of KCa3.1 Promotes Human Airway Smooth Muscle Cell Phenotypic Modulation.

Activation of AMPK suppresses S1P-induced airway smooth muscle cells proliferation and its potential mechanisms

Down-regulation of PTTG1 suppresses PDGF-BB-induced proliferation, migration and extracellular matrix production of airway smooth muscle cells (ASMCs) by regulating PI3K/AKT/mTOR signaling pathway

Irisin suppresses PDGF-BB-induced proliferation of vascular smooth muscle cells in vitro by activating AMPK/mTOR-mediated autophagy

PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway

PPARγ activation inhibits PDGF-induced pulmonary artery smooth muscle cell proliferation and migration by modulating TERT

PDGF mediates pulmonary arterial smooth muscle cell proliferation and migration by regulating NFATc2

MiR-138 Suppresses Airway Smooth Muscle Cell Proliferation Through the PI3K/AKT Signaling Pathway by Targeting PDK1

Estrogen receptor beta signaling inhibits PDGF induced human airway smooth muscle proliferation

Circular RNA circ_0002594 regulates PDGF-BB-induced proliferation and migration of human airway smooth muscle cells via sponging miR-139-5p/TRIM8 in asthma

Smooth muscle-specific HuR knockout induces defective autophagy and atherosclerosis